跳至主要内容
临床试验/NL-OMON45119
NL-OMON45119已完成不适用

Executive and social functioning in early- and continuously-treated patients with PKU: A follow-up study 10 years later - Executive and social functioning in PKU patients

niversitair Medisch Centrum Groningen0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 99(—)

入选标准

  • - Patients meet NIH-diagnostic criteria for Hyperphenylalaninemia (HPA) or Phenylketonuria
  • - PKU patients were treated early (within one month after birth) and continuously (at least until age 12)
  • - Born after 1974 (start national screening PKU) and minimum age of 7 years at time of study
  • - Dutch speaking
  • - PKU patients who use or used Tetrahydrobiopterin (BH4) will not be excluded, but the use of this type of medication (which is being used to treat BH4-responsive HPA/PKU-patients) will be taken into account for statistical analyses (e.g. will be introduced as a covariate in between-group comparisons)

排除标准

  • - Mental retardation that has been diagnosed by the clinical centre, or if the IQ is below 80 (after assessment)
  • - Lack of fluency in Dutch
  • - Use of medication other than Tetrahydrobiopterin that may affect cognitive functioning
  • - Medical illnesses other than PKU with known effects on cognitive and social functioning

研究者

相似试验